Rebecca Mouncey

Dr. Rebecca Mouncey

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 August 2024 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
JLJessica M. Lawson
Jessica M. Lawson
SSShebl E Salem
Shebl E Salem
DMDonald Miller
Donald Miller
AKAnne Kahler
Anne Kahler
WBWilhelmina J. van Den Boer
Wilhelmina J. van Den Boer
AMAmanda M de Mestre
Amanda M de Mestre
Chromosomal abnormalities are a common cause of human miscarriage but rarely reported in any other species. As a result, there are currently inadequate animal models available to study this condition. Horses present one potential model since mares receive intense gynecological care. This allowed us to investigate the prevalence of chromosomal copy number aberrations in 256 products of conception (POC) in a naturally occurring model of pregnancy loss (PL). Triploidy (three haploid sets of chromosomes) was the most common aberration, found in 42% of POCs following PL over the embryonic period. Over the same period, trisomies and monosomies were identified in 11.6% of POCs and subchromosomal aberrations in 4.2%. Whole and subchromosomal aberrations involved 17 autosomes, with chromosomes 3, 4, and 20 having the highest number of aberrations. Triploid fetuses had clear gross developmental anomalies of the brain. Collectively, data demonstrate that alterations in chromosome number contribute to PL similarly in women and mares, with triploidy the dominant ploidy type over the key period of organogenesis. These findings, along with highly conserved synteny between human and horse chromosomes, similar gestation lengths, and the shared single greatest risk for PL being advancing maternal age, provide strong evidence for the first animal model to truly recapitulate many key features of human miscarriage arising due to chromosomal aberrations, with shared benefits for humans and equids.

11 August 2022 in Journal of Equine Veterinary Science
Verified
Journal Article
Open access
RMRebecca Mouncey
Rebecca Mouncey
JSJuan Carlos Arango Sabogal
Juan Carlos Arango Sabogal
AMAmanda M de Mestre
Amanda M de Mestre
KVKristien Verheyen
Kristien Verheyen
The study aimed to (1) describe the use of reproductive therapeutics; (2) estimate the incidence of disease and injury; and (3) describe non-reproductive medications administered during pregnancy in Thoroughbred broodmares. A prospective birth cohort was established on seven farms across the UK and Ireland. Details of dams' signalment, breeding history, reproductive management during the breeding season(s) and veterinary-attended episodes of illness or injury and medication usage during gestation were retrieved retrospectively for 275 pregnancies in 235 mares over two breeding seasons. Results are reported at pregnancy-level of mares with data available. Preoestrus medications, ovulatory agents and post-covering treatments were administered to 55% (n = 85/155, 95% Confidence interval (CI) 47-62), 64% (n = 101/157, 95% CI 57-71) and 73% (n = 109/150, 95% CI 65-79) of mares respectively. Antibiotics were utilized in 69% (n = 75/109, 95% CI 60-77) of post-covering treatments. Of mares with no visible fluid on post-covering ultrasound, 37% (n = 24/65, 95% CI 26-49) still received treatment. Thirty-four percent (n = 70/203, 95% CI 28-41) of mares suffered at least one veterinary-attended episode of disease or injury, with conditions affecting the musculoskeletal system (23%, n = 46/203, 95%CI 17-29) and placentitis (5%, n = 10/203, 95% CI 3-9) most prevalent. Forty-seven percent (n = 95/203, 95% CI 40-54) of mares received at least one non-reproductive medication during gestation, antibiotics (25%, n = 51/203, 95% CI 20-31) and non-steroidal anti-inflammatory drugs (23%, n = 47/203, 95% CI 18-29) being most frequently prescribed. Post-covering treatments often included antibiotics and were sometimes given in the absence of fluid, highlighting a need to further understand therapeutic rationale. Disease occurrence and medication usage during gestation were frequent and warrant additional investigation.

26 December 2023 in Equine Veterinary Journal
Verified
Journal Article
Open access
RMRebecca Mouncey
Rebecca Mouncey
JSJuan Carlos Arango Sabogal
Juan Carlos Arango Sabogal
AMAmanda de Mestre
Amanda de Mestre
KVKristien L. Verheyen
Kristien L. Verheyen
Background: Early‐life locomotor activity during turn out may alter susceptibility to musculoskeletal disease and injury via modulation of behaviours and tissue development during growth.Objectives: Investigate associations between turn out practices and rates of musculoskeletal disease and injury in young Thoroughbreds on stud farms in the United Kingdom.Study design: Prospective cohort.Methods: Daily records were kept on location and duration of turn out for 134 Thoroughbred foals on six stud farms, from birth until leaving the farm or study exit. Data on veterinary‐attended episodes of musculoskeletal disease or injury were collated concurrently. Average daily turn out times (hours), areas (acres) and group size (n foals) were calculated for rolling 7‐ and 30‐day periods of age. Multivariable Cox regression, including farm as a random effect, was used to investigate associations between turn out practices and musculoskeletal disease and injury.Results: The overall incidence of musculoskeletal disease or injury was 5.3 cases/100 foal‐months at risk (95% confidence interval [CI]: 4.2–6.6). Compared with 24/7 turn out, average daily turn out times of between 9 and 23 hours over a 7‐day period were associated with a 4.6‐fold increase in musculoskeletal injury rate (95% CI: 1.7–12.3; P < 0.001), adjusting for farm and paddock area. Each 1‐acre increase in the average daily turn out area during the 4th month of life, reduced the rate of musculoskeletal disease and injury between 6 and 18 months of age by 24% (hazard ratio 0.76, 95% CI: 0.58–0.99; P < 0.001), adjusting for farm and turn out time.Main limitations: Non‐random sample of participants may affect generalisability. Use of veterinary‐attended events likely underestimates disease/injury rates.Conclusions: Results suggest that disruptions or alterations to turn out time routines increase injury risk and should be avoided where possible. Turn out in larger paddocks, particularly before weaning, may confer protection against subsequent musculoskeletal disease and injury.

9 June 2024 in Veterinary Record Open
Verified
Journal Article
Open access
RMRebecca Mouncey
Rebecca Mouncey
PAPablo Alarcon
Pablo Alarcon
KVKristien Verheyen
Kristien Verheyen
Background: Industry‐level figures suggest that up to two‐thirds of Thoroughbred breeding operations in the UK are unprofitable and that around half of sales transactions of Thoroughbred yearlings, commercial breeders’ predominant income source, return a loss. The industry strategy currently endorses investment in stallion covering fee; however, to date, a comprehensive evaluation of sales price determinants in the UK setting is lacking and could better inform economic decision making to improve profitability. Methods: Sales catalogue and Weatherbys’ stud book data from all Thoroughbred yearlings sold at the 2020 Tattersalls October yearling sale in the UK were used to build a hedonic sales price model. Explanatory variables representing sire, dam, yearling and sales attributes were evaluated. The final model's accuracy was assessed using out‐of‐sample data from all yearlings sold in the equivalent 2021 sale. Results: In 2020, a total of 1506 catalogued yearlings, representing around 30% of the UK Thoroughbred foal crop, were sold, with a median price of £42,575 (interquartile range 15,750‒105,000; range 840‒3,570,000). The sires’ covering fee, maternal siblings’ race performance attributes, whether the yearling was the dams’ first foal, consignment size, catalogue book and day of sale within book significantly influenced auction price; however, relationships were complex with significant interaction and confounding observed. The mean model forecasting error was £2074. The use of data from only one sale could affect generalisability. Conclusions: These novel findings can inform breeding decisions to maximise profitability, give context for current industry strategies and can inform valuations of breeding stock.

9 February 2024 in Veterinary Sciences
Verified
Journal Article
Open access
PDF file
RMRebecca Mouncey
Rebecca Mouncey
JSJuan Carlos Arango Sabogal
Juan Carlos Arango Sabogal
PRPolly Rathbone
Polly Rathbone
CSCamilla J. Scott
Camilla J. Scott
AMAmanda M de Mestre
Amanda M de Mestre
Determining whether endometrial microbial isolates are pathogens, contaminants, or even part of the “normal” microbiome is extremely complex, particularly given the absence of “gold standard” tests for endometritis. Population-level benchmarking and temporal monitoring can provide novel insights and a wider context to improve understanding. This study aimed to (i) estimate the prevalence of endometrial isolates from swabs of Thoroughbred broodmares in Newmarket, UK between 2014 and 2020; and (ii) evaluate the effects of year, mare age, and cytology findings on isolate prevalence. Generalised linear mixed models with a logit link, both null models and models using year of sampling, mare age, or cytology findings as predictors, were fitted to estimate isolate prevalence. Over the 7-year period, data were available from 18,996 endometrial-swab samples from 6050 mares on 290 premises. The overall isolate prevalence was 35.5% (95% confidence interval (CI) 33.0–37.9), and this varied significantly between years. The most prevalent isolates were β-hemolytic Streptococcus (17.9; 95% CI: 17–19) and E. coli (10.3%; 95% CI: 9.0–11.6). Isolate prevalence increased with mare age except for E. coli isolates, and with increasing category of cytology findings except for α-hemolytic Streptococcus isolates. The results provide novel estimates of isolate prevalence and highlight knowledge gaps around potential complexities in the interpretation of findings.

14 May 2023 in Veterinary Record
Verified
Journal Article
Open access
RMRebecca Mouncey
Rebecca Mouncey
JSJuan Carlos Arango Sabogal
Juan Carlos Arango Sabogal
AMAmanda M. de Mestre
Amanda M. de Mestre
KVKristien Verheyen
Kristien Verheyen
Background: Up‐to‐date estimates of early‐life morbidity and mortality in Thoroughbreds are lacking. Methods: A birth cohort was established on Thoroughbred stud farms across the UK and Ireland. All veterinary interventions for disease or injury between birth and 18 months of age or leaving the study were recorded. Multilevel Poisson regression models with farm and foal as random effects were fitted to estimate incidence rates. Results: Data were available for 3328 foal‐months at risk for 275 foals on seven farms. The overall rates of disease and injury requiring veterinary intervention and mortality were 11.9 cases/100 foal‐months at risk (95% confidence interval [CI] 8.6–16.2) and 0.2 cases/100 foal‐months at risk (95% CI 0.1–0.4), respectively. Almost half ( n = 133/273, 49%, 95% CI 43–55) of the live‐born cohort required veterinary intervention for musculoskeletal disease or injury, equating to 5.8 cases/100 foal‐months at risk (95% CI 4.1–8.2), predominantly reported as developmental orthopaedic disease (DOD). Limitations: Convenience sampling of participants may affect the generalisability of the findings. Conclusions: Rates of musculoskeletal disease and injury, in particular DOD, on Thoroughbred stud farms were high. Further work to identify modifiable risk factors and further understanding of the economic impact of these conditions and long‐term consequences for musculoskeletal health and performance is required.